Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Leukemia

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Leukemia|May 23, 2001
Who should be transplanted for AML?F R Appelbaum
Leukemia|April 1, 1988
Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects"F R Appelbaum
Leukemia|March 17, 2000
Is there a best transplant conditioning regimen for acute myeloid leukemia?F R Appelbaum
Leukemia|July 1, 1993
Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML)F R Appelbaum
Leukemia|January 26, 2005
Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantationF R Appelbaum
Leukemia|February 13, 2002
Hematopoietic cell transplantation beyond first remissionF R Appelbaum
Leukemia|March 21, 2003
New targets for therapy in acute myeloid leukemiaF R Appelbaum
Leukemia|May 1, 1997
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)F R Appelbaum
Leukemia|October 20, 1998
Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS scoreF R Appelbaum, J Anderson
Leukemia|January 1, 1994
Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experienceD R Head, K J Kopecky, C Willman, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Leukemia|May 23, 2001
Who should be transplanted for AML?F R Appelbaum
Leukemia|April 1, 1988
Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects"F R Appelbaum
Leukemia|March 17, 2000
Is there a best transplant conditioning regimen for acute myeloid leukemia?F R Appelbaum
Leukemia|July 1, 1993
Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML)F R Appelbaum
Leukemia|January 26, 2005
Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantationF R Appelbaum
Leukemia|February 13, 2002
Hematopoietic cell transplantation beyond first remissionF R Appelbaum
Leukemia|March 21, 2003
New targets for therapy in acute myeloid leukemiaF R Appelbaum
Leukemia|May 1, 1997
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)F R Appelbaum
Leukemia|October 20, 1998
Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS scoreF R Appelbaum, J Anderson
Leukemia|January 1, 1994
Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experienceD R Head, K J Kopecky, C Willman, et al.
Pageof 4